Literature DB >> 21601876

Survival outcomes of pediatric intestinal failure patients: analysis of factors contributing to improved survival over the past two decades.

Rebecca A Hess1, Kathleen B Welch, Pamela I Brown, Daniel H Teitelbaum.   

Abstract

BACKGROUND: Intestinal failure (IF) is associated with significant and life-threatening complications. Recent studies suggest that treatments for IF in the pediatric population are improving over time. Based on this, we examined whether pediatric IF survival rates have improved in our patient population over the past two decades, and secondarily examined which aspects of patient care contributed to changes in survival.
METHODS: We conducted a retrospective chart review of all pediatric patients with IF at our children's hospital from 1990 through 2009. Cox regression analyses were used to determine change in survival rates over time (5-y cohorts), and we examined multiple covariates to determine their potential influence on survival rates over time.
RESULTS: A significant improvement in survival of 171 children with IF was noted over the past two decades. Children with an onset of IF in the 1990-1994 cohort had significantly decreased survival compared with children in all subsequent cohorts (P = 0.011). The only intervention that was identified between this time period and future periods was the establishment of a comprehensive intestinal failure clinical care team. While the latter three cohorts were not significantly different, progressively increased survival was noted. Ability to wean off parenteral nutrition (PN) and small bowel length greater than 10% of the expected length were significantly associated with improved survival over this time period (P < 0.01). Other tested covariates, including the more recent use of ethanol lock therapy (to prevent catheter sepsis) and lipid reduction strategies (to treat PN-associated cholestasis) failed to show a significant impact on improved survival.
CONCLUSIONS: Despite a striking improvement in survival of children with IF over the past two decades, the only identified intervention that significantly impacted survival was establishment of a comprehensive care team. These findings emphasize the need for multi-disciplinary efforts to care for such complex and challenging children.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21601876     DOI: 10.1016/j.jss.2011.03.037

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  30 in total

1.  The Safety and Immunogenicity of Rotavirus Vaccination in Infants With Intestinal Failure.

Authors:  Patrick J Javid; Sabrina E Sanchez; Susan Jacob; Monica M McNeal; Simon P Horslen; Janet A Englund
Journal:  J Pediatric Infect Dis Soc       Date:  2013-10-14       Impact factor: 3.164

2.  Spray Delivery of Intestinal Organoids to Reconstitute Epithelium on Decellularized Native Extracellular Matrix.

Authors:  Dana M Schwartz; Meryem O Pehlivaner Kara; Allan M Goldstein; Harald C Ott; Adam K Ekenseair
Journal:  Tissue Eng Part C Methods       Date:  2017-09       Impact factor: 3.056

Review 3.  Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure.

Authors:  Mikko P Pakarinen
Journal:  Pediatr Surg Int       Date:  2015-03-29       Impact factor: 1.827

4.  The extent of intestinal failure-associated liver disease in patients referred for intestinal rehabilitation is associated with increased mortality: an analysis of the Pediatric Intestinal Failure Consortium database.

Authors:  Patrick J Javid; Assaf P Oron; Christopher P Duggan; Robert H Squires; Simon P Horslen
Journal:  J Pediatr Surg       Date:  2017-09-05       Impact factor: 2.545

5.  Pentavalent rotavirus vaccine in infants with surgical gastrointestinal disease.

Authors:  Eric J McGrath; Ron Thomas; Christopher Duggan; Basim I Asmar
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-07       Impact factor: 2.839

6.  Attitudes Surrounding the Management of Neonates with Severe Necrotizing Enterocolitis.

Authors:  Gillian C Pet; Ryan M McAdams; Lilah Melzer; Assaf P Oron; Simon P Horslen; Adam Goldin; Patrick J Javid
Journal:  J Pediatr       Date:  2018-05-10       Impact factor: 4.406

7.  Secondary Anticoagulation Prophylaxis for Catheter-Related Thrombosis in Pediatric Intestinal Failure: Comparison of Short- Vs Long-Term Treatment Protocols.

Authors:  Melanie Lissa Schmidt; Danielle Wendel; Simon Peter Horslen; Erin Richardson Lane; Leonardo Rodrigues Brandão; Emily Gottschalk; Christina Belza; Glenda Courtney-Martin; Paul William Wales; Yaron Avitzur
Journal:  JPEN J Parenter Enteral Nutr       Date:  2020-12-06       Impact factor: 4.016

8.  Mesenteric neovascularization with distraction-induced intestinal growth: enterogenesis.

Authors:  Matthew W Ralls; Ryo Sueyoshi; Richard S Herman; Brent Utter; Isabel Czarnocki; Nancy Si; Jonathan Luntz; Diann Brei; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2013-01       Impact factor: 1.827

9.  Neurodevelopmental and Cognitive Outcomes in Children With Intestinal Failure.

Authors:  Patrick M Chesley; Sabrina E Sanchez; Lilah Melzer; Assaf P Oron; Simon P Horslen; F Curt Bennett; Patrick J Javid
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-07       Impact factor: 2.839

10.  Adaptation: paradigm for the gut and an academic career.

Authors:  Brad W Warner
Journal:  J Pediatr Surg       Date:  2013-01       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.